HeraMED Limited, a medical data and technology company, develops, manufactures, and sells home-based maternity monitoring technology in Australia and the United States. It also provides HeraBEAT, a medical device for fetal and maternal heart rate used by pregnant women; and HeraCARE, a remote fetal heart rate monitoring solution. The company has a collaboration agreement with Mayo Clinic for the development of its HeraCARE pregnancy management platform; and Broward Health for deployment of its HeraCARE to deliver care outcomes for pregnant mothers. HeraMED Limited was founded in 2011 and is based in Hawthorn East, Australia.
Metrics to compare | HMD | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipHMDPeersSector | |
|---|---|---|---|---|
P/E Ratio | −9.9x | −5.8x | −0.6x | |
PEG Ratio | −0.14 | 0.07 | 0.00 | |
Price/Book | 77.9x | 3.6x | 2.6x | |
Price / LTM Sales | 138.9x | 4.2x | 3.4x | |
Upside (Analyst Target) | - | 78.0% | 44.9% | |
Fair Value Upside | Unlock | 9.0% | 6.7% | Unlock |